Christine Fumeron

1.1k total citations
17 papers, 709 citations indexed

About

Christine Fumeron is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Christine Fumeron has authored 17 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Christine Fumeron's work include Dialysis and Renal Disease Management (9 papers), Blood Pressure and Hypertension Studies (3 papers) and Vitamin D Research Studies (2 papers). Christine Fumeron is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Blood Pressure and Hypertension Studies (3 papers) and Vitamin D Research Studies (2 papers). Christine Fumeron collaborates with scholars based in France, United States and Belgium. Christine Fumeron's co-authors include Thao Nguyen‐Khoa, Bernard Lacour, Ziad A. Massy, P Jungers, Béatrice Descamps‐Latscha, Na Man, M. Labrunie, Claude Buisson, Philippe Tuppin and C. Jacquot and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Christine Fumeron

17 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Fumeron France 12 370 226 156 82 75 17 709
Karen S. Servilla United States 17 454 1.2× 259 1.1× 211 1.4× 63 0.8× 150 2.0× 63 949
F Gómez-Campderá Spain 12 270 0.7× 157 0.7× 110 0.7× 39 0.5× 78 1.0× 19 546
Martina Reslerova Canada 16 724 2.0× 159 0.7× 171 1.1× 124 1.5× 145 1.9× 26 1.1k
Taner Baştürk Türkiye 15 397 1.1× 83 0.4× 119 0.8× 90 1.1× 105 1.4× 75 717
Amanda H. Anderson United States 12 688 1.9× 166 0.7× 137 0.9× 171 2.1× 103 1.4× 14 945
Jean-Marie Billiouw Belgium 11 338 0.9× 166 0.7× 175 1.1× 59 0.7× 163 2.2× 16 732
Robert Toto United States 7 386 1.0× 246 1.1× 94 0.6× 27 0.3× 86 1.1× 7 613
Michael P. Delaney United Kingdom 14 431 1.2× 121 0.5× 83 0.5× 46 0.6× 91 1.2× 24 686
Giuliano Barsotti Italy 21 605 1.6× 267 1.2× 170 1.1× 76 0.9× 155 2.1× 45 1.1k
Shoichi Fujimoto Japan 8 379 1.0× 119 0.5× 69 0.4× 55 0.7× 116 1.5× 13 625

Countries citing papers authored by Christine Fumeron

Since Specialization
Citations

This map shows the geographic impact of Christine Fumeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Fumeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Fumeron more than expected).

Fields of papers citing papers by Christine Fumeron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Fumeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Fumeron. The network helps show where Christine Fumeron may publish in the future.

Co-authorship network of co-authors of Christine Fumeron

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Fumeron. A scholar is included among the top collaborators of Christine Fumeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Fumeron. Christine Fumeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Chevalier, Louise, Christian Tielemans, Frederic Debellé, et al.. (2015). Isonatric Dialysis Biofeedback in Hemodiafiltration with Online Regeneration of Ultrafiltrate in Hypertensive Hemodialysis Patients: A Randomized Controlled Study. Blood Purification. 41(1-3). 87–93. 10 indexed citations
3.
Mercadal, Lucile, Mathieu Coudert, Anne Vassault, et al.. (2012). L-Carnitine Treatment in Incident Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 7(11). 1836–1842. 26 indexed citations
4.
Iliou, Marie Christine & Christine Fumeron. (2012). Cardiovascular disease in chronic renal failure patients.. PubMed. 16(2). 129–39. 1 indexed citations
5.
Bollée, Guillaume, Benoît Guéry, Dominique Joly, et al.. (2008). Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing Dialysis. Clinical Journal of the American Society of Nephrology. 3(2). 375–381. 41 indexed citations
6.
Weissinger, Eva M., Thao Nguyen‐Khoa, Christine Fumeron, et al.. (2005). Effects of oral vitamin C supplementation in hemodialysis patients: A proteomic assessment. PROTEOMICS. 6(3). 993–1000. 42 indexed citations
7.
Fumeron, Christine, Thao Nguyen‐Khoa, Claudine Saltiel, et al.. (2005). Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrology Dialysis Transplantation. 20(9). 1874–1879. 79 indexed citations
8.
Massy, Ziad A., Christine Fumeron, Didier Borderie, et al.. (2004). Increased Plasma S-Nitrosothiol Concentrations Predict Cardiovascular Outcomes among Patients with End-Stage Renal Disease. Journal of the American Society of Nephrology. 15(2). 470–476. 29 indexed citations
9.
Farhi, David, S. Oro, N. Costedoat‐Chalumeau, et al.. (2004). Épidermolyse bulleuse dystrophique récessive d’Hallopeau-Siemens associée à une glomérulonéphrite à dépôts mésangiaux d’IgA : 4 cas. Annales de Dermatologie et de Vénéréologie. 131(11). 963–967. 12 indexed citations
10.
Iliou, Marie Christine, Christine Fumeron, M.-O. Benoît, et al.. (2003). Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. American Journal of Kidney Diseases. 42(3). 513–523. 59 indexed citations
11.
Iliou, Marie Christine, Christine Fumeron, M.-O. Benoît, et al.. (2001). Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrology Dialysis Transplantation. 16(7). 1452–1458. 87 indexed citations
12.
Landais, Paul, Bénédicte Stengel, Christine Fumeron, & Christian Jacquelinet. (1998). L’insuffisance rénale terminale traitée en France : épidémiologie et système d’information. 4(7). 2 indexed citations
13.
Fumeron, Christine. (1998). J009 Renal effects of valsartan and benazepril in healthy volunteers. American Journal of Hypertension. 11(4). 179A–179A. 1 indexed citations
14.
Jungers, P, J. Zingraff, Christine Fumeron, et al.. (1997). Bénéfices d'une prise en charge néphrologique précoce de l'insuffisance rénale chronique. La Presse Médicale. 26(28). 2–5. 12 indexed citations
15.
Jungers, P, Ziad A. Massy, Thao Nguyen‐Khoa, et al.. (1997). Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrology Dialysis Transplantation. 12(12). 2597–2602. 255 indexed citations
16.
Jungers, P, Habib Skhiri, J Zingraff, et al.. (1997). [Benefits of early nephrological management in chronic renal failure].. PubMed. 26(28). 1325–5. 21 indexed citations
17.
Châtellier, Gilles, et al.. (1994). [Therapeutic approach in arterial hypertension with renal artery stenosis].. PubMed. 23(31). 1439–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen S. Servilla Breakdown of academic impact, for papers by F Gómez-Campderá Breakdown of academic impact, for papers by Martina Reslerova Breakdown of academic impact, for papers by Taner Baştürk Breakdown of academic impact, for papers by Amanda H. Anderson Breakdown of academic impact, for papers by Jean-Marie Billiouw Breakdown of academic impact, for papers by Robert Toto Breakdown of academic impact, for papers by Michael P. Delaney Breakdown of academic impact, for papers by Giuliano Barsotti Breakdown of academic impact, for papers by Shoichi Fujimoto
Rankless by CCL
2026